Antiretroviral therapy coverage for PMTCT in Myanmar

Myanmar: Antiretroviral therapy coverage for PMTCT was 54.0% in 2024. ◆ Volatile

Latest (2024)
54.0%
Change on year
down 3.6%
World rank
65th
of 84 countries
All-time high
88.0%
in 2019
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Antiretroviral therapy coverage for PMTCT in Myanmar, 2000–2024

0204060802000201220242000: 0 % of pregnant women living with HIV2001: 0 % of pregnant women living with HIV2002: 0 % of pregnant women living with HIV2003: 5 % of pregnant women living with HIV2004: 8 % of pregnant women living with HIV2005: 11 % of pregnant women living with HIV2006: 19 % of pregnant women living with HIV2007: 25 % of pregnant women living with HIV2008: 30 % of pregnant women living with HIV2009: 40 % of pregnant women living with HIV2010: 42 % of pregnant women living with HIV2011: 50 % of pregnant women living with HIV2012: 58 % of pregnant women living with HIV2013: 61 % of pregnant women living with HIV2014: 71 % of pregnant women living with HIV2015: 75 % of pregnant women living with HIV2016: 82 % of pregnant women living with HIV2017: 83 % of pregnant women living with HIV2018: 87 % of pregnant women living with HIV2019: 88 % of pregnant women living with HIV2020: 83 % of pregnant women living with HIV2021: 22 % of pregnant women living with HIV2022: 44 % of pregnant women living with HIV2023: 56 % of pregnant women living with HIV2024: 54 % of pregnant women living with HIV

Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.

Analysis

Myanmar recorded 54.0% for antiretroviral therapy coverage for pmtct in 2024.

Compared with earlier readings it is down 3.6% on the previous year and down 23.9% over ten years.

Over the whole period, antiretroviral therapy coverage for pmtct in Myanmar peaked at 88.0% in 2019 and was at its lowest, 0.0%, in 2000.

Myanmar ranks 65th of 84 countries on this measure, in the bottom quarter.

The series is highly variable year to year, so single readings are best treated with caution.

Antiretroviral therapy coverage for PMTCT in Myanmar, year by year

Annual values for Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) in Myanmar, 2000 to 2024.
Year % of pregnant women living with HIV Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 5.0%
2004 8.0% +60.0%
2005 11.0% +37.5%
2006 19.0% +72.7%
2007 25.0% +31.6%
2008 30.0% +20.0%
2009 40.0% +33.3%
2010 42.0% +5.0%
2011 50.0% +19.0%
2012 58.0% +16.0%
2013 61.0% +5.2%
2014 71.0% +16.4%
2015 75.0% +5.6%
2016 82.0% +9.3%
2017 83.0% +1.2%
2018 87.0% +4.8%
2019 88.0% +1.1%
2020 83.0% -5.7%
2021 22.0% -73.5%
2022 44.0% +100.0%
2023 56.0% +27.3%
2024 54.0% -3.6%

Myanmar compared with similar countries

  • Myanmar's 54.0% is below the median for lower middle income countries, which is 83.5%, 65% of the median. (32 countries reporting)
  • Myanmar's 54.0% is below the median for East Asia & Pacific, which is 68.0%, 79% of the median. (9 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2000s 13.8% 0.0% 40.0% 10
2010s 69.7% 42.0% 88.0% 10
2020s 51.8% 22.0% 83.0% 5

Countries ranked near Myanmar

  1. 62 Cameroon 59.0% compare
  2. 63 Fiji 57.0% compare
  3. 64 Netherlands 55.0% compare
  4. 66 Colombia 53.0% compare
  5. 67 Paraguay 52.0% compare
  6. 68 Mali 46.0% compare

See the full ranking of 99 places →

More health data for Myanmar

All data for Myanmar →

Frequently asked questions

What is antiretroviral therapy coverage for pmtct in Myanmar?
Antiretroviral therapy coverage for pmtct in Myanmar was 54.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
What is the highest antiretroviral therapy coverage for pmtct recorded in Myanmar?
The highest recorded value was 88.0% in 2019.
What is the lowest antiretroviral therapy coverage for pmtct recorded in Myanmar?
The lowest recorded value was 0.0% in 2000.
How does Myanmar rank for antiretroviral therapy coverage for pmtct?
Myanmar ranks 65th out of 84 countries with data for 2024.
Is antiretroviral therapy coverage for pmtct rising or falling in Myanmar?
Over the last ten years it is down 23.9%. The long-run trend across the full record is volatile.
Where does this Myanmar data come from?
The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Antiretroviral therapy coverage for PMTCT in Myanmar. Statizoid, drawing on UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Retrieved 17 September 2026, from https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/myanmar/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/myanmar/">Antiretroviral therapy coverage for PMTCT in Myanmar</a> — Statizoid

About this data

Indicator
Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
Unit
% of pregnant women living with HIV
Source
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
99 places, 2,393 data points, 2000–2024
Last refreshed

Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).